ScienceDex / Researcher record
Ajit K Parhi
- Taxis Pharmaceuticals, Inc. (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $910,179 | 1 | #16,828 |
| 2025 | $1,889,610 | 2 | #7,328 |
| 2026 | $2,170,527 | 3 | #9,568 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY20252 records
- FY2026 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10895937Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award records by amount
NIH award records listing Ajit K Parhi as a PI. Multi-PI records show the full award amount for context.
- 5R44AI191886-02R44Contact PILead optimization of oral DHFR inhibitor for the treatment of multidrug-resistant N. gonorrhoeae infections.$1Maward amount
- 5R44AI174351-03R44Contact PILead optimization of a novel cyclic aryl-indole efflux pump inhibitor (EPI) series in combination with levofloxacin against Pseudomonas aeruginosa$875.8Kaward amount
- 1R43AI197297-01R43Contact PILead identification of oral FtsZ inhibitors for the treatment of Clostridioides difficile infections(CDI)$294.7Kaward amount
Award organization
Organizations that administered FY2026 awards listing Ajit K Parhi as a PI.
FY2026 award administered by Taxis Pharmaceuticals, Inc. (NJ).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardTaxis Pharmaceuticals, Inc.
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #7328